Vir Biotechnology's Series A Round

Vir Biotechnology raised a round of funding on October 18, 2017.

Vir Biotechnology is focused on cures, treatments, and preventions for challenging viral and bacterial diseases, including those caused by drug-resistant bacteria and emerging pathogens.…

Articles about Vir Biotechnology's Series A Round: